T 1570/09 (Alpha-ketoglutaric acid and pharmaceutically acceptable salts thereof for use in increasing HDL plasma levels/PROTISTA) of 16.05.2014
- European Case Law Identifier
- ECLI:EP:BA:2014:T157009.20140516
- Date of decision
- 16 May 2014
- Case number
- T 1570/09
- Petition for review of
- -
- Application number
- 05752599.0
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen (C)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- USE OF ALPHA-KETOGLUTARATE AND RELATED COMPOUNDS FOR LOWERING PLASMA LIPIDS
- Applicant name
- Protista Biotechnology AB
- Opponent name
- -
- Board
- 3.3.02
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 52(4) 1973European Patent Convention Art 53(c)European Patent Convention Art 54 1973European Patent Convention Art 54(5)European Patent Convention Art 56European Patent Convention Art 69
- Keywords
- Admission of main request and first auxiliary request (Yes)
Main request: Two independent claims for the same medical use;one claim under the provisions of EPC 1973 invoking legal fiction in G 5/83, and other claim under the provisions of Article 54(5) EPC 2000 (No)
First auxiliary request: allowable (Yes) - Catchword
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the department of first instance with the order to grant a patent with the following claims and a description to be adapted thereto:
Claims 1 to 3 of the first auxiliary request filed during the oral proceedings of 16 May 2014.